Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of ...

After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National ...